Cargando…
NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy
Diabetic cardiomyopathy (DCM), a serious diabetic complication, is a kind of low-grade inflammatory cardiovascular disorder. Due to the high risk of morbidity and mortality, DCM has demanded the attention of medical researchers worldwide. The pathophysiological nature of DCM is intricate, and the ge...
Autores principales: | Zhang, Lixia, Ai, Chenchen, Bai, Ming, Niu, Jinglei, Zhang, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501057/ https://www.ncbi.nlm.nih.gov/pubmed/36142531 http://dx.doi.org/10.3390/ijms231810632 |
Ejemplares similares
-
Aloe-Emodin Derivative, an Anthraquinone Compound, Attenuates Pyroptosis by Targeting NLRP3 Inflammasome in Diabetic Cardiomyopathy
por: Hu, Yingying, et al.
Publicado: (2023) -
NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy
por: Zeng, Cheng, et al.
Publicado: (2020) -
The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy
por: Zheng, Xiaoqin, et al.
Publicado: (2023) -
Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype
por: Sallman, David A., et al.
Publicado: (2016) -
Chemerin/CMKLR1 Axis Promotes Inflammation and Pyroptosis by Activating NLRP3 Inflammasome in Diabetic Cardiomyopathy Rat
por: Xie, Yebin, et al.
Publicado: (2020)